Aktienanalyse zu Lumexa Imaging Holdings Inc (LMRI)LMRILumexa Imaging Holdings Inc

Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems. It operates in the Healthcare sector.

Lumexa Imaging Holdings, Inc. is a good buy right now due to its recent positive earnings surprise of 233.33% and a current price of $10.78, which is significantly below analyst price targets of $18 from both Truist and KeyBanc. The company has shown a recovery in net income with a positive net income of $2.74 million in Q2 2026, indicating a turnaround in profitability. However, the main risk is its high debt to equity ratio of 144.68%, which could impact financial stability if not managed carefully.